12 completed, 2 terminated, 1 withdrawn. 15 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 12, Terminated 2, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow Cancer of the Prostate: new trials by email Literature Review of Cancer of the Prostate trials Research Report on Cancer of the Prostate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC NUV-422, Enzalutamide - Prostate Cancer, Prostatic Cancer | Phase 1 / Phase 2 | Withdrawn | Nuvation Bio Inc. | 2022-09-01 | 2022-08-05 | |
| I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). I-131-1095, Enzalutamide - Metastatic Prostate Cancer, Castration-resistant Prostate Cancer | Phase 2 | Completed | Progenics Pharmaceuticals, Inc. | 120 | 2019-05-30 | 2025-10-14 |
| A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer 177Lu-PSMA617, Cabazitaxel - Cancer of the Prostate, Metastatic Cancer | Phase 2 | Completed | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 201 | 2018-01-29 | 2022-06-13 |
| Prostate Cancer Survivors and Exercise and Behavioral Counseling Supervised Physical Activity Plus Behavioral Counseling, Supervised Physical Activity Plus Exercise Counseling - Physical Activity, Cancer of the Prostate | Phase 2 | Completed | University of Illinois at Urbana-Champaign | 27 | 2017-07-06 | 2019-12-20 |
| Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer Apalutamide - Cancer of the Prostate | Phase 2 | Completed | Singapore General Hospital | 30 | 2017-06-20 | 2020-03-19 |
| Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone Enzalutamide, Metformin - Cancer of the Prostate, Prostate Cancer | Phase 2 | Terminated | Swiss Cancer Institute | 169 | 2016-06-10 | 2023-06-27 |
| Maintaining Suppression of Testosterone With Transdermal Estradiol Gel BHR-200 (0.36% transdermal 17β-estradiol gel), Placebo - Cancer of the Prostate | Phase 2 | Terminated | BHR Pharma, LLC | 34 | 2015-07-01 | 2022-03-31 |
| Sipuleucel-T Manufacturing Demonstration Study sipuleucel-T - Cancer of Prostate, Cancer of the Prostate | Phase 2 | Completed | Dendreon | 47 | 2012-06-01 | 2015-12-09 |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer androgen ablation (AA), DC1 vaccine - Cancer of Prostate, Cancer of the Prostate | Phase 2 | Completed | Roswell Park Cancer Institute | 13 | 2009-09-01 | 2020-11-03 |
| Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E, Placebo - Cancer of the Prostate, Prostate Cancer | Phase 2 | Completed | University Health Network, Toronto | 48 | 2008-10-01 | 2017-10-26 |
| Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E, Placebo - Cancer of the Prostate, Prostate Cancer | Phase 2 | Completed | University Health Network, Toronto | 16 | 2008-05-01 | 2018-02-14 |
| A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer IPI-504 - Prostate Cancer, Prostatic Neoplasms | Phase 2 | Completed | Infinity Pharmaceuticals, Inc. | 19 | 2007-11-01 | 2012-12-11 |
| Vessel Sparing Prostate Radiation Therapy Radiation Therapy - Cancer of the PROSTATE | Phase 2 | Completed | University of Michigan Rogel Cancer Center | 135 | 2004-11-01 | 2018-03-05 |
| Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer Dendritic cell application - Cancer of the Prostate | Phase 1 / Phase 2 | Completed | Cantonal Hospital of St. Gallen | 15 | 2002-11-01 | 2015-08-17 |
| A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy YM155 - Prostate Cancer, Cancer of Prostate | Phase 2 | Completed | Astellas Pharma Inc | 2012-06-07 |
Prostatic Neoplasms (15) · Male Urogenital Diseases (2) · Cognitive Dysfunction (1) · Motor Activity (1) · Neoplasm Metastasis (1) · Prostatic Neoplasms, Castration-Resistant (1)
Genital Diseases (15) · Genital Diseases, Male (15) · Genital Neoplasms, Male (15) · Neoplasms (15) · Neoplasms by Site (15) · Prostatic Diseases (15) · Urogenital Diseases (15) · Urogenital Neoplasms (15) · Male Urogenital Diseases (13) · Behavior (1) · Cognition Disorders (1) · Mental Disorders (1) · Neoplastic Processes (1) · Neurocognitive Disorders (1) · Pathologic Processes (1)
enzalutamide (3) · Cholecalciferol (2) · Lycopene (2) · Selenium (2) · Tea (2) · Vitamin E (2) · Behavior Therapy (1) · Metformin (1) · Pluvicto (1) · Radiotherapy (1) · apalutamide (1) · cabazitaxel (1) · sepantronium (1) · sipuleucel-T (1) · tanespimycin (1)
University Health Network, Toronto (2) · Astellas Pharma Inc (1) · Australian and New Zealand Urogenital and Prostate Cancer Trials Group (1) · BHR Pharma, LLC (1) · Cantonal Hospital of St. Gallen (1) · Dendreon (1) · Infinity Pharmaceuticals, Inc. (1) · Nuvation Bio Inc. (1) · Progenics Pharmaceuticals, Inc. (1) · Roswell Park Cancer Institute (1) · Singapore General Hospital (1) · Swiss Cancer Institute (1) · University of Illinois at Urbana-Champaign (1) · University of Michigan Rogel Cancer Center (1)
United States (8) · Canada (3) · Netherlands (2) · United Kingdom (2) · Australia (1) · Austria (1) · France (1) · Singapore (1) · Switzerland (1)
Neil Fleshner (2) · Andrew Stubbs, PhD (1) · Art F Kramer, PhD (1) · Christian Rothermundt, MD (1) · D. Buell, MD (1) · Daniel Spratt, MD (1) · Edward McAuley, PhD (1) · Jean-Claude Provost, MD (1) · Kendrith M Rowland, MD (1) · Leonard J Appleman, MD, PhD (1) · Linda Trinh, PhD (1) · Lui Shiong Lee, MBBS,MRCS (1) · Michael Hofman, A/Prof (1) · Thomas Cerny, Prof. Dr. (1)
PMID 28233591, PMID 31595044, PMID 32979134, PMID 33581798, PMID 34373282, PMID 35091711, PMID 36000794, PMID 36261050, PMID 36350899, PMID 38043558, PMID 40425844